WHO ICTRP trial
probiotic reducing post procedure infection in biliary malignancy
CTRI/2022/08/045015 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/08/045015 |
|---|---|
| Public title | probiotic reducing post procedure infection in biliary malignancy |
| Scientific title | Effect of Periprocedure Lactobacillus reuteri in reducing Bactobilia in patients with Malignant Biliary Obstruction with Percutaneous transhepatic biliary drainage :A pilot randomised control study |
| Primary sponsor | ILBS |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: C23- Malignant neoplasm of gallbladder |
| Interventions | Intervention1: probiotic: Giving probiotic for 4 weeks twice daily Intervention2: Probiotic L reuteri 109 bacillus: for 4 weeks twice daily per orally along with standard treatment as mentioned in comparator. Control Intervention1: no agent… |
| Registration date | Aug 29, 2022 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: